Dear Subscriber:
Following the merger of Thomson Corporation and Reuters earlier this year, we no longer update the forum. We would like to thank you for your support and participation. For the latest news and analysis on healthcare and pharmaceuticals, please visit http://www.reuters.com/finance/industries/healthcare
We would also like to extend to you an offer to continue your relationship with Thomson Reuters. Please click on the link below if you would like to become a member of the Reuters Insight Expert Network.
http://www.reutersinsight.com/pages/mail_landing?campaignId=190001
Reuters Insight is an independent research consultancy owned by Thomson Reuters. Through the Reuters Insight Community of Experts we connect our clients with topic area experts for paid consultations. These clients include sophisticated investment decision makers and corporate leaders in North America, Asia and Europe.